Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History LNSR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics LNSR

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

LENSAR Inc

LNSR
Current price
13.10 USD -0.16 USD (-1.21%)
Last closed 13.14 USD
ISIN US52634L1089
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 156 431 712 USD
Yield for 12 month +166.26 %
1Y
3Y
5Y
10Y
15Y
LNSR
21.11.2021 - 28.11.2021

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System. The company offers LENSAR Laser System which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida. Address: 2800 Discovery Drive, Orlando, FL, United States, 32826

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

15.00 USD

P/E Ratio

Dividend Yield

Financials LNSR

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures LNSR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+53 494 000 USD

Last Year

+42 164 000 USD

Current Quarter

+14 159 000 USD

Last Quarter

+16 731 000 USD

Current Year

+25 851 000 USD

Last Year

+21 107 000 USD

Current Quarter

+7 125 000 USD

Last Quarter

+7 108 000 USD
EBITDA -2 933 000 USD
Operating Margin TTM -11.05 %
Price to Earnings
Return On Assets TTM -6.31 %
PEG Ratio
Return On Equity TTM -304.05 %
Wall Street Target Price 15.00 USD
Revenue TTM 57 065 000 USD
Book Value -1.88 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 33.70 %
Dividend Yield
Gross Profit TTM 27 312 000 USD
Earnings per share -4.86 USD
Diluted Eps TTM -4.86 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin -99.17 %

Stock Valuation LNSR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 2.29
Price Sales TTM 2.74
Enterprise Value EBITDA -1.04
Price Book MRQ 2.17

Technical Indicators LNSR

For 52 Weeks

3.50 USD 17.31 USD
50 Day MA 13.29 USD
Shares Short Prior Month 172 463
200 Day MA 10.45 USD
Short Ratio 1.62
Shares Short 470 996
Short Percent 1.99 %